Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-09-28

FDA Approved: XYOSTED — Original Application (Antares Pharma, Inc.)

View source ↗

Summary

FDA approved XYOSTED (testosterone enanthate) through its original NDA submitted by Antares Pharma, establishing a new drug product for male hypogonadism.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • XYOSTED (Testosterone enanthate)

Snippet

ORIG AP for XYOSTED (TESTOSTERONE ENANTHATE)